Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by ROY FLEISCHMANN
Longterm Safety of Patients Receiving Rituximab in Rheumatoid Arthritis Clinical Trials
Journal of Rheumatology
Rheumatology
Allergy
Immunology
Dr. Fleischmann Replies
Journal of Rheumatology
Rheumatology
Allergy
Immunology
Related publications
Safety of Rituximab in Rheumatoid Arthritis
Reumatismo
Rheumatology
Rituximab Therapy in Greek Patients With Rheumatoid Arthritis
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
Clinical and Immunological Effects of the Original and Biosimilar Rituximab in Patients With Rheumatoid Arthritis
Clinical pharmacology and therapy
FRI0224 Rituximab Selectively Reduces Igg4 Levels in Rheumatoid Arthritis Patients
Long-Term Safety of Rituximab in Rheumatoid Arthritis: Analysis From the SUNSTONE Registry
Arthritis Care and Research
Rheumatology
NK Cell Count as Predictor of Clinical Response in Patients With Rheumatoid Arthritis Treated With Rituximab
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
Risk of Malignancies in Patients With Rheumatoid Arthritis Treated With Rituximab: Analyses of Global Postmarketing Safety Data and Long-Term Clinical Trial Data
Rheumatology and Therapy
Infections in Patients With Rheumatoid Arthritis Receiving Anti-Cytokine Therapy: Biological Mechanisms and Clinical Aspects
Reumatismo
Rheumatology
Drug Trials in Rheumatoid Arthritis
InPharma
